Capital expenditure decreased 78.4%
Capital expenditure changed -78.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -78.4% from the comparable as-filed period.
Cash & equivalents changed +20.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed +20.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -477 basis points from the comparable as-filed period.
Operating cash-flow margin changed -589 basis points from the comparable as-filed period.
Capex / revenue changed -111 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +522 basis points from the comparable as-filed period.
Revenue changed +0.7% from the comparable as-filed period.
Working capital / assets changed +203 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -11.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -4.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -45 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +8.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +10.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current liabilities changed -1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.